SCHEMBL7718610

SCHEMBL7718610

C=C1/C(=C/C=C2\CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C(=O)C4(C(=O)N(C)C)CC4)CC[C@@H]23)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 11/20 0.46
▸ ADRA1A P35348 2/20 0.45
▸ NR1I2 O75469 1/20 0.45
▸ PGR P06401 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ LMNA P02545 2/20 0.42
▸ AR P10275 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ ESR1 P03372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8995650 0.94 VDR (0.48) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8527095 0.93 VDR (0.47) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL7716494 0.93 VDR (0.47) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8995605 0.92 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8193233 0.91 VDR (0.45) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL5379813 0.90 VDR (0.47) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL5378802 0.90 VDR (0.47) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL7713305 0.90 VDR (0.52) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL7716298 0.90 VDR (0.52) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL7714416 0.90 ALDH1A1 (0.51) VDRADRA1ANR1I2PGRHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376480-B1 TREATMENT OF IMMUNE SYSTEM DISORDERS, OSTEOPOROSIS, ALOPECIA SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-23 — — US disclosed
US-6372731-B1 TREATMENT OF CELL PROLIFERATION AND BONE DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-16 — — US disclosed
Send feedback